Search

everythinglearnresearchcommunity

for

Search:↓

Gray hair can potentially be managed or reversed with treatments that boost melanin production and address nutritional deficiencies.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

Hair loss is caused by genetics, hormones, stress, and environment, and can be managed with good nutrition, stress control, and treatments.

Managing inflammation and using vitamins can improve PRP therapy for better hair growth.

Graves' disease is a common cause of hyperthyroidism, mainly in women, treated with medication, iodine, or surgery, with varying outcomes.

Women with female pattern hair loss may have a higher risk of metabolic syndrome.

Premature graying and hair changes can be treated with certain peptides and possibly targeting the endocannabinoid system.

Low iron levels are strongly linked to chronic hair loss in women.

The skin acts like an endocrine organ, producing hormones that affect various body functions and skin health, and understanding this can lead to new treatments.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

The seed extract of Lepidium sativum L. can potentially treat hair loss, showing effects similar to 5% minoxidil.

New understanding and treatments for hair loss are improving, but more research is needed.

The patient's hypothyroidism improved with medication adjustments and careful management.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

A misdiagnosed case of HAIR-AN syndrome led to unnecessary surgeries and highlighted the importance of correct diagnosis and treatment.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

A new treatment for hair loss was tested and most participants saw their hair loss stop within 2-8 weeks, with up to 50% more hair after 4 months, and no side effects.

A woman's hair loss led to discovering she had lupus.

Zebrafish help understand genetic causes of skin pigment disorders like albinism.

Hormone levels can help predict metformin treatment success in women with PCOS.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Moderately high prolactin levels do not cause hair loss in women.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

Higher fluoride levels may delay puberty in boys.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Lower irisin levels in the blood may indicate more severe acne.